Different effects of oligomycin and dicyclohexylcarbodiimide on ATPases from mammalian cells.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000818:Animals; D002417:Cattle; D002462:Cell Membrane / Q000201:enzymology*; D003510:Cyclohexanes / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004336:Drug Antagonism; D004789:Enzyme Activation; D004912:Erythrocytes / Q000166:cytology / Q000201:enzymology*; D006801:Humans; D007668:Kidney / Q000201:enzymology*; D008660:Metabolism / Q000187:drug effects; D008930:Mitochondria, Liver / Q000201:enzymology*; D009206:Myocardium / Q000201:enzymology*; D009829:Oleic Acids / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology*; D010042:Ouabain / Q000494:pharmacology; D010743:Phospholipids / Q000494:pharmacology; D010744:Phosphoric Monoester Hydrolases; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D014280:Triglycerides / Q000494:pharmacology
D003510:Cyclohexanes; D009829:Oleic Acids; D009840:Oligomycins; D010743:Phospholipids; D014280:Triglycerides; D010042:Ouabain; D012964:Sodium; D010744:Phosphoric Monoester Hydrolases; D000251:Adenosine Triphosphatases; D011188:Potassium